We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Apple
AAPL
$4.54T
| $17.2M | 0.16% |
655,184
-924,208
| -59% | -$26.4M |
|
152
Brown-Forman Class B
BF.B
$13B
| $17M | 0.16% |
534,756
+514,443
| +2,533% | +$17.2M |
|
|
XEC
153
DELISTED
CIMAREX ENERGY CO
XEC
| $16.9M | 0.16% |
188,728
+175,317
| +1,307% | +$19.5M |
|
154
Ameriprise Financial
AMP
$49.6B
| $16.5M | 0.16% |
155,467
-59,879
| -28% | -$6.69M |
|
155
FirstEnergy
FE
$27.7B
| $16.4M | 0.15% |
+516,998
| New | +$16.2M |
|
156
IQVIA
IQV
$38.9B
| $16.3M | 0.15% |
+237,870
| New | +$16.3M |
|
|
ITC
157
DELISTED
ITC HOLDINGS CORP
ITC
| $16.3M | 0.15% |
+415,690
| New | +$14.4M |
|
|
MON
158
DELISTED
Monsanto Co
MON
| $16.2M | 0.15% |
164,382
-4,697
| -3% | -$441K |
|
|
WBMD
159
DELISTED
WebMD Health Corp.
WBMD
| $16.2M | 0.15% |
334,978
+285,692
| +580% | +$12.7M |
|
|
FDC
160
DELISTED
First Data Corporation
FDC
| $16.2M | 0.15% |
+1,009,929
| New | +$16.6M |
|
161
Akamai
AKAM
$17.8B
| $16.2M | 0.15% |
306,921
+285,025
| +1,302% | +$17.5M |
|
|
TGI
162
DELISTED
Triumph Group
TGI
| $16.1M | 0.15% |
+405,575
| New | +$16.4M |
|
|
AMSG
163
DELISTED
Amsurg Corp
AMSG
| $16.1M | 0.15% |
211,199
-16,519
| -7% | -$1.31M |
|
164
Applied Materials
AMAT
$424B
| $15.9M | 0.15% |
850,194
-85,335
| -9% | -$1.48M |
|
165
BioMarin Pharmaceuticals
BMRN
$11.6B
| $15.9M | 0.15% |
151,448
-74,724
| -33% | -$7.8M |
|
|
HDS
166
DELISTED
HD Supply Holdings, Inc.
HDS
| $15.9M | 0.15% |
527,916
+319,537
| +153% | +$9.59M |
|
167
Newell Brands
NWL
$2.63B
| $15.7M | 0.15% |
+357,191
| New | +$15.6M |
|
168
Flex
FLEX
$45B
| $15.7M | 0.15% |
1,855,173
+1,827,352
| +6,568% | +$15.4M |
|
169
Paylocity
PCTY
$7.91B
| $15.5M | 0.15% |
382,997
+19,999
| +6% | +$768K |
|
170
Fidelity National Financial
FNF
$13.8B
| $15.3M | 0.14% |
635,461
+163,049
| +35% | +$3.98M |
|
171
DexCom
DXCM
$31.2B
| $15.2M | 0.14% |
743,332
-33,064
| -4% | -$688K |
|
172
Capital One
COF
$136B
| $14.9M | 0.14% |
205,781
-375,700
| -65% | -$28.8M |
|
173
Delta Air Lines
DAL
$61.3B
| $14.8M | 0.14% |
292,028
-125,489
| -30% | -$6.21M |
|
|
BRCD
174
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $14.6M | 0.14% |
1,594,605
-243,198
| -13% | -$2.39M |
|
|
TMX
175
DELISTED
Terminix Global Holdings, Inc.
TMX
| $14.6M | 0.14% |
+555,169
| New | +$13.5M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.